Table 2.
Correlation between the clinicopathological features and expression of the CK2α protein.
| CK2α (%) | ||||
|---|---|---|---|---|
| Characteristics | N | Low expression | High expression | P |
| Gender | 0.646 | |||
| Male | 56 | 22 (39.3) | 34 (60.7) | |
| Female | 48 | 21 (43.8) | 27 (56.2) | |
| Age | 0.897 | |||
| ≥55 y | 54 | 22 (40.7) | 32 (59.3) | |
| <55 y | 50 | 21 (42.0) | 29 (58.0) | |
| Tumor location | 0.554 | |||
| Colon | 53 | 21 (39.6) | 32 (60.4) | |
| Rectum | 51 | 22 (43.1) | 29 (56.9) | |
| T stage | 0.002* | |||
| T1-T2 | 49 | 21 (42.9) | 28 (57.1) | |
| T3-T4 | 55 | 15 (27.2) | 40 (72.7) | |
| N stage | 0.515 | |||
| Nx-0 | 55 | 20 (36.4) | 35 (63.6) | |
| N1-2 | 49 | 23 (46.9) | 26 (53.1) | |
| M stage | 0.632 | |||
| M0 | 60 | 26 (43.3) | 34 (56.7) | |
| M1 | 44 | 17 (38.6) | 27 (61.4) | |
| TNM stage | 0.539 | |||
| I-II | 30 | 11 (36.7) | 19 (63.7) | |
| III-IV | 74 | 32 (43.2) | 42 (56.8) | |
| Degree of differentiation | 0.632 | |||
| Well | 35 | 13 (37.1) | 22 (62.9) | |
| Moderately | 45 | 21 (46.7) | 24 (53.3) | |
| Poorly | 24 | 9 (37.5) | 15 (62.5) | |
*Statistically significant difference.